Shenzhen Bioeasy Biotechnology Co.,Ltd.’s Net Profit Rose 276.9% in First Three Quarters of 2021
Shenzhen Bioeasy Biotechnology Co.,Ltd. (深圳市易瑞生物技术股份有限公司) (300942.SZ) reported a net profit of 195.6 million yuan in the first three quarters of 2021, up 276.9% year-on-year.
Meanwhile, the company posted 431.1 million yuan in revenue, up 131.1% year-on-year.
At the end of the reporting period, it had 1.1 billion yuan in total assets and 205.9 million yuan in total liabilities, with a liability-to-asset ratio of 18.6%.
This article was automatically produced by Caixin Automation on Nov. 3, 2021.
Download our app to receive breaking news alerts and read the news on the go.
Follow the Chinese markets in real time with Caixin Global’s new stock database.
- MOST POPULAR